Inactivation of <scp>SARS‐CoV</scp>‐2 infectivity in platelet concentrates or plasma following treatment with ultraviolet C light or with methylene blue combined with visible light
Jody Hobson‐Peters(The University of Queensland), Helen M. Faddy(Brisbane School of Theology), Stefan Reichenberg(Macopharma (Germany)), Alexander A. Khromykh(The University of Queensland), Alberto A. Amarilla(Commonwealth Scientific and Industrial Research Organisation), Ute Gravemann(German Red Cross), Daniel Watterson(The University of Queensland), Axel Seltsam(Medizinische Hochschule Hannover), Denese C. Marks(The University of Sydney), Eileen Roulis(Australian Red Cross Lifeblood), Frank Tolksdorf(Macopharma (Germany)), Lina Rustanti(Australian Red Cross Lifeblood), Chryslain Sumian(Macopharma (France)), Naphak Modhiran(The University of Queensland)
Cited by 3
Related Papers
SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike protein
|Molecular Psychiatry|2022|178
A versatile reverse genetics platform for SARS-CoV-2 and other positive-strand RNA viruses
|Nature Communications|2021|177
Detection of dengue virus in saliva and urine by real time RT-PCR
|Virology Journal|2010|134